SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 48 filers reported holding SCPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,365,000 | +25.7% | 355,690 | 0.0% | 0.03% | +14.8% |
| Q4 2020 | $1,882,000 | -29.5% | 355,690 | -0.8% | 0.03% | -34.1% |
| Q3 2020 | $2,671,000 | -6.6% | 358,535 | -7.7% | 0.04% | -4.7% |
| Q2 2020 | $2,860,000 | +329.4% | 388,603 | +119.4% | 0.04% | +330.0% |
| Q4 2018 | $666,000 | -50.8% | 177,135 | -23.3% | 0.01% | -33.3% |
| Q3 2018 | $1,355,000 | +3.8% | 230,819 | 0.0% | 0.02% | +25.0% |
| Q2 2018 | $1,306,000 | -52.9% | 230,819 | +3.3% | 0.01% | -47.8% |
| Q1 2018 | $2,771,000 | +31.0% | 223,438 | +27.7% | 0.02% | +35.3% |
| Q4 2017 | $2,116,000 | – | 175,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |